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We have evaluated localized capaciti ve radiofrequency hy-
perthermia in the trea tment of murine S91 m elanom a. Two 
hundred and ten D B A /2] m ale mice w ere implanted with 
1 X 106 S91 murine melanom a cells innoculated into a 
noninflammato ry upper dermal suction blister cavity. T wo 
tumors were implanted per animal, so that each animal 
served as its own control in evaluating the effects of tem-
perature, trea tment duration , and tumor size on tumor 
growth followin g radio frequency hyperthermia trea tment . 
The data supported the following conclusions: (1) capaci-
H yperth ermia (high temperature hea tin g) as a can-cer trea tm ent modality is based on the premise that mali gnant cells are sensitive to thermal effects [1]. This premise is suppo rted by a large body of data. Hea ting to temperatu res above 42°C produces 
an increase in blood fl ow in no rm al tissues with a decrease in 
tumor blood flow, thus ca using ineffi cient tumor hea t dissipati on 
[2,3J. T his sluggish tum or blood fl ow leads to vascul ar occlusion 
and tu mor necrosis [4]. Decreased blood fl ow followin g hea tin g 
al.so res ults in a decrease in pH, which enhances thermal killin g 
and inhibits the repair o f hea t damaged cells [5] . Inhibition of 
thermal repair prevents the development o f cellular tolerance [6, 7J . 
T his prevents th e ex pansion of a hea t-resistant cell clone. Hy-
perthermia also causes cell dea th in those cells, thus creatin g a 
low pH environment [8,9]. This contras ts with radi ati on, which 
can only kill well oxygenated cells in a norm al pH environment, 
making hyperth ermi a a valuable trea tment m odality in rapidly 
growing tum ors such as melanoma where a substantial cell pop-
ulation has a low pH due to hypoxia [9J. In addition, hyperthermia 
sensitivity of cells is greatest during the S- phase of the cell cycle, 
th e period w hen cells are mos t res istant to radiation damage. Thus 
hyperthermia may offer an additional tumor kill advantage when 
combined with radiation [1 0J. Other preferential tumor metabolic 
alterations following hi gh temperature heating include a marked 
depression of oxidative m etabolism , increased form ation of Iy-
sosomes accompanied by lysoso mal rupture, and decreased syn-
thesis of RNA, DNA, and pro teins [llJ . Evidence also exists that 
hyperthermia causes stimulation ofT cells and macrophages, which 
may aid in tum or regression [12,13J. 
Modalities to produce hyperthermia include water bath , ultra-
sound , radiofrequency, and microwave. The manner in w hi ch 
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tive radiofrequency h yperthermia is effective in the trea t-
ment of murine S91 melanoma; (2) duration of trea tment 
between 10 and 60 seconds at 52°C does no t influence ef-
fectiveness; and (3) trea tment temperatures > 49°C are needed 
for maximal effecti veness in the trea tment of these tumors. 
Based on these preliminary findings , high temperature, 
short duration capacitive radiofrequency hyperthermia may 
prove to be a useful modality in the treatment o f certain 
cutaneous m alignancies. J In vest D ermatol 89:518- 522, 1987 
hea t is produ ced de termines the degree, depth , and pattern of 
heatin g. Water bath tumor immersion cann ot produce loca lized 
heatin g [1 4J. Ultrasound (0.2-3 mHz) produ ces a nonuni fo rm 
heatin g pattern [15} . Microwave (915-2450 mHz) produces ex-
tensive depth penetration r1 6, 17J. We chose to eva luate capaciti ve 
radi ofrequency (0.5-1 3. 56 mH z) hyperthermia in the trea tment 
o f cutaneOllS murine melanoma since a uni fo rm heating pattern 
is produ ced w ith a depth penetration suffi cient to heat a derm all y 
im planted tumor. 
MATERIALS AN D METHODS 
Animal Model T wo hund red and ten D B A /2] male mice Uack-
son Labs, Bar Habor, M aine) weighing between 20 and 25 g were 
housed in mesh cages, 5 anirnals per cage, with a constant supply 
of standard mouse chow and wa ter. 
A subclone of C loud man S91 murine melanoma cells has been 
maintained continuollsly fo r the pas t 5 yea rs by growth in syn-
geneic D BA /2] mice and subsequ ent cultiva tion of tumor cells in 
75-cm plastic fl asks w ith 25 ml o f nutrient mixture F-1 0, heat 
inactivated 2% fetal calf serum, 10% horse serum, 10 m g/ ml of 
strepto m ycin , and 100 U / ml of penicillin G. The media were 
replaced every 3- 4 days and subcultures were carried out weekl y 
using 0. 2% edetic acid [1 8]. Cells fo r in vivo implantation were 
always taken from one of the fi rst three in vitro subculture passages. 
The animals were intra cutaneously implanted w ith 1 X 106 
murine S91 melanoma cells. Intracutaneous implantation was ac-
complished by innoculatin g cells into an upper derm al blister 
cavity [1 8J crea ted by a suction blister device that consisted of a 
200 m gH g vacuum punlp attached to a specially designed suction 
head consistin g of fi ve 5-mm round o rifi ces, w hich were placed 
in contact with the shaved animal's back. Fi ve minutes of suction 
appli ca tion resulted in the formati on of a noninflamm atory bulla 
in the upper dermis into whi ch the S91 mu rine melanoma cells 
were implanted , thus mimicking a melanoma metas tas is. Two 
tumors were implanted per anim al to allow each mouse to act as 
its own control. Tumors were all owed to grow fo r time periods 
of 1, 3, 5, 7, 9, and 11 days after implantation befo re treatment 
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Figure 1. Hand-held radiofrcq ucncy hyperthermia Ulllt w ith self-con-
taIned battery. Hcating occurs bctween the two probes that arc gentl y 
p laced ill contact w ith the 110rmal sa lin c moistened trcatmcnt site. 
to eva lu ate the effecti veness of radio frequency heatin g on va ryin g 
tumor sizes, sin ce the tum ors enl arged rapidl y after implantati on. 
The therapeutic effecti veness was assessed after 24 days of post-
treatment o bserva tio n. The tumor implantation si tes were excised 
a nd the tum ors were dessicated overni ght in a drying oven and 
then weig hed. The differen ce between contro l and treated tumor 
weights was used as an endpo int for ev:duat ion of treatment re-
sponsc. Anim als could o nly be followcd for 24 days, sin ce the 
contro l tumors o ften bega n to enlarge to the point of interfering 
w ith th e anim al's no rm al functionin g. 
Hyperthermia Apparatus A hand-h eld , 2 mH z capacit ivc ra-
d iofreq ucncy generator (Fig 1) (HDM Engineerin g, Phoeni x, Ar-
izona) was used to ad minister the hyperthermi a. The unit was 
powered by a wa ll rcchargea ble battery contain ed within the de-
v ice, w hi ch powered a 2 mH z radiofrequency sin e wave ampli-
tu de m odulated oscillato r w ith a maxi mum 10 wa tt o utput, w hi ch 
sent the hig h frequen cy electri c current to a bipolar surface probe. 
The probe was placed in contac t w ith skin on either side of the 
tumor and the resistance of the tissue to current fl ow produced 
internal hea t generation . The sensin g arm of the probe co ntai ned 
a th ermistor th at monito red the sk in surface tempera ture, and 
e lect ronic feedback was used to contro l the ap plied power. The 
e lectrostatic field was achieved by placing the two arms of the 
probe on opposing sides o f the tumor; thus the tissue became part 
of the dielectri c of a ca pacitor. The probe arm s contain ed com-
pensating inductive coils tuned to the circuit to neutralize the 
ca pacitive reactance between th e electrodes and the ti ssue to max-
imize the hea ting co mponent of the current in the tissue. The 
distance between th e probes was 3 mm resu ltin g in 3 X 3 111m 
s quare heating area. Three overl apping fields were used in our 
treatments resu lting in a 9 X 9 mm sq uare treatment area. 
The radiofrequency unit had an initial hea tin g period w here-
upon ano th er oscill ator sig naled the attainment of the trea tm ent 
temperature. We exa mined m ean trea tment tem peratures of 42°C, 
49°C, 50°C, and 52°C and 10, 30, and 60 seconds of heatin g. The 
various tempera tures were obtained by in creas in g the power of 
the electric current delivered to the tissue. 
Coupling between the cutaneo us probe and the shaved anim al's 
back was acco mplished by m ois tenin g the skin w ith norm al sa-
line, w hich aided in hea t transfer. Depending upon the hydra tio n 
cha racteristics of the sk in containin g the tumor and the content 
of the underl yin g tiss ue (i. e., bone or fa t), the resis tance of the 
skin ca n vary between 50 Ohms and 500 O hm s. M oistening the 
tissue decreases the resistance and pro vi des for even surface hea t-
ing. The layer of fa t found benea th the dermis in skin also in sures 
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Figure 2. Therlllogr"phic ca mcra reprcsentatio n of the 3 x 3 1111n sq uare 
hea ting arca produced by capaciti ve rad iofreq uency between the twO probes 
is demons trated in the upper fra me. T he lower fram e g raph ica lly shows 
that the heating is rcs tri cted to the tumor contai ned betwcen the surface 
probes. 
surface hcatin g sin ce it is thermall y and electrica ll y Icss condu cti ve 
than m oistened skin , and thus insulates th c decpcr tissues. 
Telnperature Measurelnent Cutaneous temperature mea-
surcmel1ts were taken by a th erm ographi c cam era and implanted 
thermocouplc temperaturc sensors. T he thermog raphi c ca mera 
(Fig 2) was used to obtain mean surfacc temperatures over the 
treatment period, sin ce both convecti vc and conductive therm al 
losses caused so me te mperature va ri ation . When treatmen t tem-
pe ratures arc discussed, we are expressing the m ean tum or surface 
temperature as observcd by the therm ograp hi c ca mera during the 
treatment period. 
C utaneous depth tempcraturc was eva lu ated by usin g insul ated 
and shielded copper-constantan miniature thermocoup lcs and a 
di g ital rcado ut m eter (Senso rtck, Saddle Brook, N ew J ersey) in-
SCI-ted throug h a 16-ga ugc ca th cter into a melanoma tum o r. As 
expected, tempera tures decreased as depth in creased. For exam-
ple, w hen the h ypc rth ermia uni t was set for a treatment tem-
perature of 50°C, the sur face tcmperature of 50°C was maintain ed 
to a depth of 3 mm with hyperthermi c heating above 43°C oc-
currin g to a depth of 5 mm . A temperature of 36°C could be 
detected down to 13 mm. T he baseline body temperature of the 
anim al was 32° . The superficial nature of the hea tin g in sured 
that full thickness necrosis of the skin wo uld not occur. 
HESULTS 
Posttreatment Appearance All animals treated developed mild 
second degree burns at th e sites of the hyperthermia treatments. 
Punch biopsies performed at 24 h posttreatmcnt revealed a ne-
crotic epidcrmis w ith via bl e basal ceUs in th e hair fo llicles in the 
dermis. By 72 h posttreatmcnt, hyperplastic epithel ium was scen 
arising fi-o m reg iona l fo llicul ar epithelium (da ta not shown). A ll 
anim als hea led w ith minimal scarring and no hyperth ermia as-
sociated fatali ties oCCll rred during o r immed iately after treatment. 
Clinical Effects of Hyperthermia 
Treatlllent Telllpemtllre Va riatioll : Wc chose to eva lu ate the effect 
of tempera turc on tumor growth by exami nin g treatmcnt tem-
peratures of 42°C, 49°C, SO°C, and S2°C on one day old tumors 
trea ted for 30 seco nds. Figure 2 demonstrates that treatment tem-
perature affects melanoma recurrence rate. There were fi ve re-
currences in 37 anim als at tempcratures >49°C com pared with 
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Figure 3. Treatment temperature va riation. Treatment temperatures > 49°e 
are most effecti ve in thc trea tmcnt of 59 1 murine melanoma tumors. 
eight recurrences in 15 animals at 42°C (p = 0.018). However, 
the m ortality associated w ith increased tumor treatment temper-
atures was notable w ith four deaths at 52°C, two deaths at both 
50°C and 49°C, and no dea th s at 42°C. The dea ths in these animals 
occurred at leas t 2 weeks after treatment and were not du e to 
tumor burden sin ce in all cases the control tumor had not necrosed 
a,~d no gross ev idence of tumor remained at the trea tm ent site. 
The deaths could possib ly be attributed to the fact that a 9 X 9 
mm burn site represe nts approximately 5% of the animal's to tal 
body surface area, w hich represented an insult. 
Temperatures > 49°C appear to be the most effective with no 
signifi cant diffe rence between the recurren ce rates for 49°C , 50°C, 
and S2°e. A 9% recurrence rate (1/11 anim als) was noted at 52°C 
compared w ith a 23% recurrence rate (3 / 13 anim als) at 50°C and 
an 8% recurrence rate (1/13 anim als) at 49°C (Fig 3) . Over half 
of the anim als (53%) d eveloped recurrences w hen treated at 42°C. 
C lea rly, sho rt duratio n 42°C hyperth ermia is not effective in the 
trea tm ent of small murine melanoma tumors. All surviving an-
innIs hea led with the minim al sca rrin g and co mplete ha ir re-
growth over the treat m ent site. It is concluded that temperatures 
> 49°C ca n be used success fu ll y for short durations in melanoma 
treatment w ith rap id hea lin g of the treated site. 
A group of 20 anim als were trea ted at 52°C for 30 seconds and 
fo llowed for 113 days postimplantation . The tumors were seven 
days old and approx imately:; mm in diameter when treated . 
These animals were fol lowed to determine the long-term response 
to a single h yperthermi a treatment. T here were two recurren ces 
out of the 20 an imals with death occurring in the anima ls exhib-
iting recurrences prio r to day 113. An add iti onal two anim als 
w itho ut tumor recurren ce at their tim e of death died of unk nown 
ca uses. Therefore, ·16 out of20 (80%) of th e anim als ex perienced 
a lon g-term tum or cure. 
Treatmen t Time Variation: We chose to evaluate the length 
of hyperthermia treatment in relati on to tumor growth by treating 
one-da y-o ld tumors at 52°C for 10, 30, and 60 seconds. T he data 
in Fig 4 demonstrate that there is no difference in effectiveness 
of hyperthermia treatment between 10, 30, and 60 second treat-
ment durations . The effectiveness o f a 52°C trea tment tempera-
ture again was associated w ith some mortality (four deaths in 15 
anim als). Surprisingly, no anim als di ed at the lon gest 60-second 
trea tment period, but three anima ls were lost at 30 second and 1 
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Figure 4. Treatment tim e variation. Duration oft rcatmcnt time between 
10 and 60 seconds at sl oe does not influence effectiveness. 
animal at 10 second treatment periods. Only one recurrence was 
noted in all 3 g roups and this occurred with a 10 second trea tm ent 
period . These data suggests that it is the init ial exposure to high 
temperatures that ca uses the majority of the small tumor cell kill 
perhaps due to a vascu lar response. Shorter treatment times did 
offer the advantage of more rapid trea tment site hea li ng w ith less 
cutaneous scarring (data not shown). We are curren tly in vesti-
ga ting these concepts in larger tumors. 
We evaluated the effectiveness of radiofrequency hyperthermia 
on tumor size as m easured in days postimplantation (tumor size). 
Tumors of 1, 3, 5, 7 , 9, and 11 days duration were treated for 
30 seconds at 52°e. As shown in Fig 5, there is a lower rate of 
melanoma recurrence fo r tumors treated in the ea rly growth phase 
prio r to nod ule formation under 7 111m in diameter. The 1 x 106 
cell innoculum fo rmed a thin 5- mm diam eter tumor at 1 and 3 
~ 
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Figure 5. Tumor volu me va riation. Hyperthermia treatment is most 
effective in thin melanoma tumors. 
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days postimpl antation with a 15% recurrence rate (4/27 anim als). 
At 5 and 7 da ys postimpl antation , the tum o rs continued to g row 
horizonta ll y to 6 mm diameter and a recurrence ratc o f21 % (6/28 
animals) was noted. By day 9, the tlIm o rs had begun to increase 
in height as we ll as diamctcr. T he m ean hcig ht was 3 mm and 
the mea n diam eter was 7 mm. By thi s time it appears th at the 
tumo r had grown to the ma ximal height that the hyperthermia 
devicc cou ld reli ably trea t. We fo un d a '13% rccurren ce ratc (2/ 15 
anim als) . Tumo rs at day 11 postimplalltatio n had a m ean hcight 
of 4 mm w ith an 8 mm diam eter, thereb y cxceedin g the depth 
penetration of th c desircd 52°C treatm ent temperature . There was 
a 40% recurrence rate (6/15 anim als). We still noted a res ponse 
to trea tment with tum ors that we rc 4 111m thi ck as hea ting oc-
c urred at that depth; ho wc vcr, bascd on o ur tcmperaturc mea-
Surement data, it is likely that the des ired trea tm cnt tcmperature 
of 52°C was not attained at a 4 mm depth . We we re probabl y 
h ea tin g the 4 mm deep tum o r cells to 48°C, w hi ch is bclow the 
49°C temperature 'INC have dcmonstrated to be effcctivc for th cse 
s mall tumors at a trea tm ent duratio n of 30 scco nds. 
D ISCUSSIO N 
We ha ve dcmonstrated th at 2111 Hz radiofrcqu cncy hyperthcrmia 
is effec ti ve in th e treatm ent of cutan eous murin c melan o m a. It 
appea rs that hi gher temperature hca tin g m ay be th c o ptimum 
tLeatm ent strategy fo r small tum o rs, thus all owing for max imal 
tumo r kill w hile minimi zin g treatmellt duration . Storm and co l-
leagues havc prev iousl y show n that tum o rs subj ectcd to rJdiofrc-
guency heatin g havc a hi gher tcmperaturc than surroundin g 
normal ti ssue du e to dccreased hea t dissipation 11 9.1 . A sho rtcr 
t r ea tment duration at tcmperatures above 42°C is possible sin cc 
a n in crease o f a sing le deg ree o f tcmperaturc w ill decrease th e 
exposure time by a factor of two to achievc the sa me amou nt of 
cell killing 1.20]. it is not kno w n, however, how this rclat ionsh ip 
va rics fo r tcmpcraturcs as hi gh as 50-52°C. O thcr hypcrthermic 
treatment strategies include: hi gh intensity ultraso und at tcm-
peratures of 43-45°C fo r 30 minutcs [21'1. mi crowavc at tcmper-
a tures of 42-43.5°C for 45 minutcs 122], and wa tcr bath at 42 .5°C 
for 30-120 minutes [23]. These lo ng hea tin g periods bcco me cum-
bersome w hen multiplc sites rcquire trcatm cnt. 
Rad io frcquency hyperthermia has been successfull y uscd by 
o thers in thc treatm cnt of malignancy . Dickson and co lleagucs 
tLeated rabbit hind limb intramuscular VX2 ca rcinomas w ith 13.56 
mHz radiofrequcn cy h yperthcrmia noting co mpletc rcg ress io n in 
7 out of 10 tum o rs [24]. Grier and cowo rkers used 2 mH z ra-
diofrequency hyperth ermia to trea t 45 ocular squ amous ccll ca r-
cinomas in cattle and ho rses rcsultin g in 80% co mplete and 16% 
partial reg ression [25]. Sugaa r and associatcs treatcd 3 lun g cancer 
patients w ith 13.56 mH z radiofrequcn cy prior to surgica l removal 
of the tumorous lun g and noted massive tum or necrosis [261· We 
have add ed to thi s cxperiencc by dcmonstratin g the utility of 
radiofrcquency h yperthermi a in murine melanoma . Some o f thc 
limitations of this technology, however, werc illu strated by our 
data. We were onl y able to success full y t reat 7-mm-diamcter 
tumors under 4 mm in depth. The dcpth limitation is advanta-
geo us in that it prohibits production of a third degrce burn , but 
it also does not allow adcqu ate trcatm cnt of thi ck tumor nodules. 
The diam eter limitation can be overco mc by ovcrl apping treat-
m .cnt fi elds. Our rccurrences wcre probably based on in adequatc 
d e pth penetration and inadequ atc overlapping o f treatment fields. 
M any tumor trea tm ent mod aliti cs with bo th chcmotherapy and 
radiation thcrapy arc effective at killin g malignant cell s, but are 
th emselves ca rcin ogenic. H yperthermi a has never been shown to 
b e ca rcinogenic and is onl y wea kl y mutagenic 1.27] . Therefo re, 
hyperthermi a docs no t indu ce tumors as a result of trca tm ent. 
H yperthcrmia ca n easil y be combined w ith other cance r trca t-
mcnt modalitics to in crease tumor kill. H eatin g and radiation ca n 
b e co mbined additively since h yperthcrmi a dama ges hypoxic cells 
pLefercnti all y and radiation preferentiall y kills well oxygenatcd 
cell s [28- 30]. H yperthermia ca n also bc used prior to surgery to 
d ecrease tumor load or even to treat the field surrounding the 
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tum o r to dest roy mi crosco pic foci of tum o r 131] . Las tly, hyper-
th crmi a can be co mbin ed w ith chem otherapy to aug m ent tum or 
kill 132 1. "!Ie arc currentl y in ves ti ga tin g th csc stratcgics in our 
laborato ry. 
In summ ary, we havc dem onstrated thc fo ll owin g: (1) Capa-
citi ve radiofrcq ucncy hypc rtherm ia is cffccti ve in th c trcatmcnt 
of s111 all murinc S9 'I mclano m a tum o rs. (2) Dura tion of trea tm ent 
bctween 10 and 60 scconds at 52°C docs no t influence effectivcness 
in small tum o rs. (3) Trcatm cnt tempc raturcs > 49°C arc most 
cffective in the t rea tm ent of small murin c S91 m clano ma tum o rs 
fo r a trcatmcnt durati on of30 seco nds. Bascd o n these preliminary 
findin gs , hi gh-tempcrature sho rt-durati on capaciti ve radiofre-
qu cncy hyperthcrmia dcscrvcs m o re stud y in the trca tm cnt o f 
cutan co us m ali gnancies . Studics arc currently in progress to assess 
fractionatcd doscs at rcla ti vely lowe r temperatures in an cffo rt to 
design thc optimal treatment protocol. 
We ,"i;" {() (" 'Ill/" JllrI lI l/asq ll eZ' alld Scott DOll fo r ("eir ('",r"IIC//( ('("II ieni 
assistallce. 
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